PRICARA.COM Print Close Window

Medical Education

Important Information
OMJSA Vision
Medical Education Vision

 

IMPORTANT INFORMATION
Ortho-McNeil Janssen Scientific Affairs, LLC (OMJSA's) Medical Education Department is responsible for administering OMJSA's support of independent education activities for the following operating companies:

  • Janssen®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
  • McNeil Pediatrics ™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
  • Ortho-McNeil™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
  • Ortho-McNeil Neurologics ®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
  • Ortho Women's Health & Urology™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
  • PriCara®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

We are dedicated to providing support for independent educational activities that are intended to improve patient care.

Please explore the pages on these sites to learn more about our educational grants process, how to contact the Medical Education (ME) department, for the required templates needed when applying for an educational grant, and the therapeutic areas of interest for which grant applications are considered.

Before you begin the application process, please review the "Guidelines" section before proceeding to "Submit/View Request". A Letter of Request and a Budget are required for all grant applications.

PLEASE NOTE: Due to system requirements, there is a 60 minute time allotment for completion of our application. There is no 'save' feature. You will not be able to save your work and return later. Incomplete applications will not be processed.

This site is for educational grant applications only. If you are a 501(c)3 organization requesting support for a charitable event (e.g. gala, dinner, run, walk, fundraiser), please forward an e-mail message to Contributions@janus.jnj.com.

Back to top

 

OMJSA VISION
OMJSA is committed to supporting education through independent educational activities, including continuing education (CE) and non-CE activities. OMJSA's Medical Education Department (MED) is responsible for administering OMJSA's support of independent education activities for the following operating companies:

 

  • Janssen®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
  • McNeil Pediatrics™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
  • Ortho-McNeil™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
  • Ortho-McNeil Neurologics™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
  • PriCara®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
  • Ortho Women's Health & Urology™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

 

MED has prepared this information to assist Accredited and other Educational Providers in preparing grant requests for submission to our organization.

MED adheres to a strict policy governing independent education activities. Our policy is based on guidelines set by government agencies (e.g., FDA, OIG), accrediting organizations (e.g., ACCME, AAFP, ANCC, ACPE), industry (e.g., PhRMA), and medical associations (e.g., AMA). One of the goals of our policy is to ensure that the Accredited Provider/Educational Provider retains all control governing the program, and OMJSA does not exercise any direct or indirect influence over any aspect associated with an independent educational program or activity.

Back to top

 

MEDICAL EDUCATION VISION

To lead the pharmaceutical industry in quality Medical Education by addressing the educational needs of healthcare providers and ultimately improving patient outcomes, with an organizational infrastructure that is approachable and responsive.

Back to top

PriCara�
© Ortho-McNeil-Janssen Pharmaceuticals, Inc. 2005-2010. All rights reserved.

Your use of the information on this site is subject to the terms of our Legal Notice. Please see our Privacy Policy.

This site is published by PriCara®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, which is solely responsible for its contents.

This information is intended for the use of our customers, patients and healthcare professionals in the United States only. PriCara® recognizes that the Internet is a global communications medium; however, laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country. The Prescribing Information included here may not be appropriate for use outside of the United States. Capitalized product names are trademarks of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

This page was last modified on: Jul 20 2010 at 13:49:52 EDT